Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Sotio has raised $316.6M in total funding. The most recent round was Private Equity. The last funding was announced in December 2021.
Sotio's investors include PPF Group.
Sotio is headquartered in Prague, Czech Republic.
Sotio is a biotechnology company developing a new immunotherapy based on activated dendritic cells for the treatment of cancer.
Sotio is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sotio — Funding & Investors." VCBacked, December 2, 2021, https://www.vcbacked.co/company/sotio. Accessed September 30, 2026.
VCBacked. (2021). Sotio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sotio
{{cite web |title=Sotio — Funding & Investors |url=https://www.vcbacked.co/company/sotio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated